Le Lézard
Classified in: Environment, Health
Subjects: TDS, STP, ENI, FVT

DaVita Joins Mayor Hancock's Sustainable Denver Summit as Presenting Sponsor


DENVER, Dec. 4, 2017 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, is proud to join Mayor Michael B. Hancock and community leaders as the presenting sponsor at the third annual Sustainable Denver Summit.

On Dec. 5, the Sustainable Denver Summit will cap off a year-long process that engaged the community ? businesses, non-profits, government agencies and residents ? in developing and implementing specific written commitments to action and projects that will help Denver achieve its 2020 Sustainability Goals. The 2015 and 2016 Summits produced over 170 commitments combined.

DaVita's sustainability mission and vision aligns with that of the city of Denver's, with complementary goals focused on water, energy and carbon reduction and recycling.

"We are excited to serve in Mayor Hancock's Office of Sustainability, where pragmatic and creative ideas can be shared and tested," said Kent Thiry, chairman and CEO of DaVita. "Cities and countries throughout the world are grappling with these challenges.  Let's learn from them. Let's lead them."

The theme of this year's summit is "growing responsibly." As Denver grows, its increased density creates both opportunity and challenges. Sustainability leaders from across the Denver area will gather at the summit to discuss solutions to managing this growth in a sustainable way.

About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end-stage renal disease. As of September 30, 2017, DaVita Kidney Care operated or provided administrative services at 2,470 outpatient dialysis centers located in the United States serving approximately 218,200 patients. The company also operated 230 outpatient dialysis centers located in 11 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico, Pennsylvania and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/About.

Contact Information
Media:
Caitlyn Major
303.876.7547
[email protected]

DaVita logo. (PRNewsFoto/DaVita)

 

SOURCE DaVita Inc.


These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: